title: [Prevention of serogroup B meningococcal disease using a four-component vaccine].
abstract: BACKGROUND
  Meningococcal disease is an infection caused by Neisseria meningitidis, and those of serogroup B are currently the most predominant. It has been difficult to create effective vaccines for this serogroup in order to modify or reduce its morbidity. The aim of this study was to review existing data on the new vaccine 4CMenB and its potential contribution to the prevention of this infection.
  
  
  METHODS
  A panel of 12 experts (from Pediatrics, Public Health and Vaccinology) conducted a literature search and prioritized 74 publications. A review of the vaccine was then prepared, which was discussed in a meeting and subsequently validated by e-mail.
  
  
  RESULTS
  4CMenB vaccine, based on four components (NadA, fHbp, NHBA and OMVnz), was designed by reverse vaccinology. The Meningococcal Antigen Typing System (MATS) shows a potential of 70-80% coverage of the strains in Europe. Clinical trials show that the vaccine is safe and immunogenic in infants, children, adolescents, and adults, and induces an anamnestic response. The incidence of fever is similar to systemic vaccines administered alone, but higher when co-administered with them, although the fever pattern is predictable and self-limited. It is compatible with the Spanish routine vaccines, and can be administered simultaneously with the currently available hexavalent and pentavalent vaccines, as well as the pneumococcal conjugate vaccine.
  
  
  CONCLUSIONS
  The 4CMenB vaccine is the only strategy currently available to prevent meningococcal disease caused by serogroup B.
authors.affiliation: Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Madrid, España. Electronic address: angel.gil@urjc.es.
authors.forename: A
authors.initials: A
authors.lastname: Gil
authors.affiliation: Técnico de Salud Pública, Madrid, España.
authors.forename: D
authors.initials: D
authors.lastname: Barranco
authors.affiliation: Especialista en Medicina Preventiva y Salud Pública, Barcelona, España.
authors.forename: J
authors.initials: J
authors.lastname: Batalla
authors.affiliation: Servicio de Medicina Preventiva, Centro de Vacunación de Adultos, Hospital Clínic, Barcelona, España.
authors.forename: J M
authors.initials: JM
authors.lastname: Bayas
authors.affiliation: Servicio de Medicina Preventiva y Epidemiología, Hospital Vall d'Hebron, Barcelona, España.
authors.forename: M
authors.initials: M
authors.lastname: Campins
authors.affiliation: Centro de Salud Pasai San Pedro, Pasaia, Gipuzkoa, España.
authors.forename: P
authors.initials: P
authors.lastname: Gorrotxategi Gorrotxategi
authors.affiliation: Especialista en Medicina Preventiva y Salud Pública, Valencia, España.
authors.forename: J
authors.initials: J
authors.lastname: Lluch
authors.affiliation: Unidad de Cuidados Intensivos Pediatría, Hospital Clínico Universitario de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, España.
authors.forename: F
authors.initials: F
authors.lastname: Martinón-Torres
authors.affiliation: Unidad de Enfermedades Infecciosas y Tropicales Pediátricas, Servicio de Pediatría, Hospital Carlos III, Madrid, España.
authors.forename: M J
authors.initials: MJ
authors.lastname: Mellado
authors.affiliation: Unidad de Infectología Pediátrica, Hospital Materno-Infantil Carlos Haya, Málaga, España.
authors.forename: D
authors.initials: D
authors.lastname: Moreno-Pérez
authors.affiliation: Servicio de Medicina Preventiva, Complexo Hospitalario Universitario de Ourense, Orense, España.
authors.forename: B
authors.initials: B
authors.lastname: Uriel
authors.affiliation: Laboratorio de Referencia de Meningococos, Instituto de Salud Carlos III, Madrid, España.
authors.forename: J A
authors.initials: JA
authors.lastname: Vázquez
mesh_terms: D002648:Child; D006801:Humans; D008589:Meningococcal Infections / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D038541:Neisseria meningitidis, Serogroup B; D017778:Vaccines, Combined
chemical_list: C570015:4CMenB vaccine; D022401:Meningococcal Vaccines; D017778:Vaccines, Combined
keywords: Meningitis; Meningitis meningocócica; Meningococcal; Meningococcal vaccines; Prevención y control mesh terms; Prevention and control [subheading]; Vaccines; Vacunas; Vacunas antimeningocócicas